WO1987003509A1 - Method for the assembly of polar-nonpolar-polar proteolipid membranes - Google Patents

Method for the assembly of polar-nonpolar-polar proteolipid membranes Download PDF

Info

Publication number
WO1987003509A1
WO1987003509A1 PCT/SE1986/000563 SE8600563W WO8703509A1 WO 1987003509 A1 WO1987003509 A1 WO 1987003509A1 SE 8600563 W SE8600563 W SE 8600563W WO 8703509 A1 WO8703509 A1 WO 8703509A1
Authority
WO
WIPO (PCT)
Prior art keywords
membrane
lipid
interphase
peptide
nonpolar
Prior art date
Application number
PCT/SE1986/000563
Other languages
French (fr)
Inventor
Erik Audunn CERWÉN
Original Assignee
Cerwen Erik Audunn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerwen Erik Audunn filed Critical Cerwen Erik Audunn
Publication of WO1987003509A1 publication Critical patent/WO1987003509A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D69/00Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/12Composite membranes; Ultra-thin membranes
    • B01D69/122Separate manufacturing of ultra-thin membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures

Definitions

  • This invention relates to the formation of a membrane from peptide and lipid constituents, intended for use as a structural basis far further incorporation of biomolecules carrying out a function.
  • non-fragile polar-nonpolarpolarpolar membrane is one of the most important ones in contemporary biochemistry.
  • the applications of such membranes, once stable ones can be made, are numerous, and could be expected to speed up the development in fields of applied biochemistry in which the biological functions of molecular components are used artificially to generate transmembraneous electrical potentials, currents, and/or fluxes of low molecular weight compounds.
  • One such example of a potentially useful transmembraneous gradient is the photo-mechanical energy conversion mediated by bacteriorhodopsin, in which case light is directly transformed into mechanical work (1).
  • Another category of examples would be in vitro correspondances to cases when the plasma membrane receptors upon binding the appropriate ligands bring about, directly or indirectly, a change of the trans-membraneous potentials.
  • the latter category of examples would include glucose receptors, glucose and amino acid transporters, membrane-bound immunoglobulins which are part of a trans-membrane potential -modulating system, receptors for growth factors, various ion channels and other carrier molecules. Obviously, these examples are of considerable clinical and medical importance.
  • bioelectrici ty, biopotentials and/or biocurrertts where biomolecules are used and where they have to be anchored, linked or bound to a polar-nonpolar-polar (PNP) membrane might be possible to concieve in the future.
  • PNP polar-nonpolar-polar
  • lipid bilayers The fragility of lipid bilayers is well known to researchers in the field and is primarily due to the fact that they mostly are stabilized in the plane parallel to the surface of the membrane by weak, or at least transient hydrophobic interactions, and by transient hydrogen bonds between the polar residues of the lipid. These conditions permit long range diffusion of the individual lipid molecules above the phase transition point, when the lipid is "liquid” or "fluid". Many attempts have been made and published previously to "cross-link” the lipid at its polar residues, binding it to polar, high molecular weight com pounds or surfaces. These attempts present the disadvantage that the short range interactions between the individual lipid molecules will have to adapt to any long range changes of the high molecular weight cross-linker or the surface.
  • the cross-linker or the surface expands or contracts on the long range scale, the covalently bound lipid will be farced to move in between its short range neighbours in the plane of the membrane and the lipid or any other molecules inserted into the membrane will be perturbed.
  • the physico-chemical properties of the surface or the cross-linker and, in particular, their expansion coefficients given in per cent change of length or area per unit change of any exterior conditions such as temperature, pH, ionic strength or composition of the buffer may not. be the same as those of the lipid bilayers.
  • Another disadvantage of using a long-range cross-linker or surface external to the lipid bilayer is that any transmembraneous events, such as fluxes and/or changes of electrical potential, will not easily be recorded, due to the presence of the extra diffusion barrier.
  • lipid bilayers when considered far medical use in the body is the tendency of such lipid to bind to other components present there. It is well known, for example, that lipid binds to albumin and the various lipoproteins present in plasma. Of course, this leads to that the lipid disappears from any structure where it would have been placed to form a membrane as soon as that structure is placed inside the body.
  • interphase peptides In the original theory of "interphase peptides" (2,3) it has been suggested that they are stabilized by hydrophohic contact with other peptides and/or lipid, which is in accordance with the so called “hydr oph ob ic effect", and would thus seem to be thermodynamically possible. ("The hydrophobic effect” is a term denoting the finding that polar and nonpolar solvents form separate phases). In addition, it has been suggested (2,3) that interphase peptides are stabilized by hydrogen bonds and salt bridges. These features will allow the membrane to have many properties similar to those of lipid bilayers (3).
  • That interphase peptides are thermodynamically stable or, more precisely, in accordance with the hydrophobic effect means that according to the original theory, conditions would be possible t ⁇ establish when they form spontaneously at a hydrophobic - hydrophilic interphase. Since hydrophobic interactions are predominantly van der Vaals interactions involving fluctuating dipole moments of almost equivalent nonpolar groups of adjacent micelles, the formation of an interphase peptide at a hydrophobic surface of a solid or at that ⁇ f a liquid would not be expected to be qualitatively different from each other. Howevsr, due to the thermal agitation within a nonpolar liquid, it can be anticipated that the formation of an interphase peptide at such a boundary would take longer time than at the boundary of a nonpolar solid.
  • the present invention describes a method to assemble a core structure of a membrane based on interactions between interphase peptides and lipid, without any claim regarding the detailed applications of such a membrane.
  • the method described will be passible to optimize.
  • many techniques have been published on how to incorporate functional proteins into lipid monolayers or lipid bilayers, and on the conditions which are suitable for this. Since the membrane described here is partly based on lipid, it can be anticipated that future attempts to incorporate functional proteins into it would rely, at least partly, on previous work on lipid monolayers or bilayers.
  • the interphase peptide is farmed from a solution of poly-L-lysine (4-5 g/l), MW 15-30.000, or specifically 20- 25.000) in 0.4 M KOH at approximately 0°C on top of which ethyl ether is layered.
  • the aqueous phase conditions are essentially those given in previously published experiments (4), the only difference being that the solid hydrophobic surface has been replaced by a liquid one. Since interphase peptides are thermodynamically stable (3), these conditions would not be critical, and other conditions suitable for the formation ⁇ f interphase peptides would be possible to establish by any skilled experimentalist who has knowledge of the chemical and physical properties of the peptide at various pH values and for all ranges of molecular weights.
  • the incubation at approximately 0oC is continued until a layer of inter phase peptide is detectable, for example by visual inspection. This may require that the incubation at 0°C is continued far approximately a week, using the specified conditions. It is advisable to interrupt the incubation before the peptide is folded into the organic phase so that the membrane becomes rough on the nonpolar side. The conditions given are probably not the best far settling a stable interphase peptide and would be possible to optimize by modulating the ionic strength, the temperature, any other variable or the choice of organic solvent.
  • the experiments can be carried out such that one ml of organic solvent is layered on top of one ml of aqueous phase in a cylindrical glass vial of 9 mm diameter having a flat bottom.
  • a cylindrical tube On the bottom in the aqueous phase and below the phase boundary has been placed (before the solvent is added) a cylindrical tube the upp er end onto wh ich has been stretched and glued a por ou s supporting membrane and along one side of which has been attached a long glass capillary extending to the top of the glass vial to serve as a handle.
  • the tube should not be made from teflon or any other material which strongly adsorbs palylysine
  • the purpose of this devise is to lift the interphase membrane from below after it has formed and it should be devised in such a way that there is no vigorous movement of liquid in the aqueous phase below the membrane when it is lifted from the surface of the remaining liquid. It is desirable that the supporting membrane is smooth and that the pores in it are small since such conditions will decrease the probability that cracks appear in the interphase membrane when it is lifted. It is possible to avoid that the liquid inside the tube drops out of the tube when it is lifted, by making the lower end of the tube more narrow than its average inner diameter.
  • the present invention does not relate to the type of supporting membrane used and many choices are possible.
  • a most simple and readily available choice is the transparent membrane which is used in the household for protecting food and is known under various commercial names such as "gladwrap", "surround-wrap” or "handi-wrap".
  • This type of membrane may be chosen far the experiments and glued onto the above-mentioned tube with alkali-resistant glue after which it is perforated with a needle as sharp-pointed as possible. Far further aptimation, it is desirable to select membranes which are smooth and have smaller pores. If the interphase peptide is formed from an alkaline solution, the supporting membrane should be alkaliresistant.
  • the purpose ⁇ f using porous supporting membranes is that trans-membraneous events taking place across the interphase membrane will be passible to record using standard techniques.
  • the membrane or the devise which have been described are not optimal but merely a conveniant way for any handy person to lift a planar interphase membrane from a surface or an interphase. It is desirable to make the devise smaller since this will decrease the probability of cracks in the interphase membrane, but on the other hand, this might require that the whole process of lifting the membrane is performed using some standard micro-manipulator.
  • the tube has a diameter of 5 mm and a height of 8 mm.
  • One advantage of the devise that has been described is that the nonpolar part of the interphase membrane is exposed and can be sealed to any other similarly formed membrane, the nonpolar part of which is exposed. Due to the "hydrophobic effect", the two membranes, one of which contains interphase peptide, will bind to each other, this being the essential feature of the invention. Many other types of devises can also be imagined, which would accomplish the same thing.
  • a significant advantage of using ether in the method described, as compared to many other organic solvents is that it easily can be evaporated, leaving the hydrophobic part of the interphase open to air.
  • Another organic solvent which is not volatile could be expected to be more difficult to remove and might thicken the nonpolar part of any PNP-membrane of which it forms a constituent to the extent that it would be impossible for inserted functional molecu les to carry out any vectorial trans-membraneous function.
  • thermodynamically stable (cf. 3) interphase peptide are not altered if the choice of organic solvent is altered, as long as the solvent does not contain any amount of polar groups. Also the shape of the solvent molecules will be of importance and it is advisable to check each solvent for its suitability to bind the peptide.
  • the interphase peptide is incubated with lipid.
  • lipid is regarded in its widest sense, as a group of amphiphilic elongated compounds composed of at least one polar group at one end and at least one nonpolar group at the apposite end, which definition may include, for example certain detergents.
  • this is allowed for by incubating the peptide with lipid, which, according to the original theory, stabilizes the membrane by interacting with the peptide in the nonpolar plane, a plane of hydrogen bonding, and a plane of salt bridges (3). None ⁇ f these interactions is a covalent bond, which allows a certain flexibility of movement of the compounds forming the membrane, similarly to the case of lipid bilayers.
  • the lipid is added in the organic phase either in a few ul of chloroform - methanol or in a few ul ⁇ f ether or in any other suitable solvent. If a heterogeneous mixture of lipid is used, many different kinds of interactions between the lipid and the protein will be passible and the chances are better that the pores between the amino acid units are filled out. However, any type of amphiphilic lipid capable of settling at the poIar-nonpolar boundary will fill out the pores and improve the fitting between the various residues. It should be remembered that there is competition for the boundary by the peptide and the lipid and if too much lipid is added, it may completely replace the peptide.
  • a heterogenic mixture of lipid can, for example, be prepared by dissolving one egg yolk to a total volume of 100 ml in 10 mM potassium phosphate buffer, pH 7.4, containing 0.15 M of potassium chloride, mixing it with 100 ml of chloroform - methanol (2:1), then extracting 50 ml of this mixture with 100 ml of chloroform and filtering the organic phase through several (5) layers of filter paper so that it becomes clear.
  • the resulting clear organic phase can be used in the method described here.
  • the extraction of lipid from various raw materials has been well described in the literature and many other ways to prepare lipid are known.
  • lipid fractions containing less cholesterol than the one specified above can be obtained and used for the present invention.
  • the lipid is added to the organic phase after the interphase peptide has formed ⁇ r while it is being formed, as long as it does not interfere with its formation. Using the conditions specified above, it is added to the organic phase after approximately 10 days of incubation with the paly-L-lysine, and the incubation at 0°C is then continued overnight. Excess lipid is then removed by carefully replacing the organic phase several times with pure ether.
  • lipid t ⁇ the organic phase is convenient, and preferrable to adding it in the aqueous phase, in which case it may form micelles and may not enter the boundary due to steric hindrance from the peptide or electrostatic factors.
  • lipid is added from the aqueous phase or the organic phase is not critical for the present invention as long as it does not dissolve the interphase peptide into the polar or nonpolar phases.
  • lipid can be expected to fill out existing pores more or less efficiently and the method has yet to be optimized in this respect.
  • To make a stable membrane it is desirable to optimize the nonpolar interactions, the hydrogen bonding and the salt bridges within the membrane, as stated in the original theory (3).
  • a way of doing this is to select a heterogeneous mixture of lipid and expect that the best fitted lipid will settle at the boundary and that the final proteolipid boundary will represent the thermodynamically most stable condition, excluding un-fitted lipid species.
  • the interacting lipid species can be identified, they can be added specifically in well-defined amounts, but this will hardly affect the mechanisms of the formation of the proteolipid membrane, which is formed as a result of thermodynamic farces.
  • the thus formed proteolipid membrane is joined to a similarly formed proteolipid membrane which has been collected on another supporting membrane and another lifting devise of the same type, in such a way that the nonpolar parts of the proteolipid membranes are brought into contact. It should be remembered that when the ether has evaporated, one important factor in keeping the proteolipid membrane together is lost and it is desirable to join the two membranes as soon as possible.
  • the proteolipid membrane described here provides stabilization parallel to the plane of the membrane without any claim regarding the intactness of the membrane.
  • the membrane described may contain pores and/or cracks the amount of which may vary depending on the skill of the experimentalist. Therefore, the membrane should be regarded as a PNP-membrane with a predominantly nonpolar core and suitable for optimation of its sealing perpendicular to its plane, as well as of its stability parallel t ⁇ the membrane.
  • the proteolipid membrane in addition t ⁇ joining the proteolipid membrane to another similarly formed membrane, it can be joined to a lipid monolayer formed in a conventional way an the surface of an aqueous solution and pressed together to form as high a density ⁇ f lipid per surface unit as possible.
  • the aqueous phase should have approximately the same ionic strength and pH as that on the polar side of the proteolipid membrane.
  • the PNP-membrane described in the method of the invention may be subject to limited proteolytic digestion after its formation. Then, the composition of the buffer should be such that it does not destabilize the membrane.
  • This invention relates to the formation of a membrane from peptide and lipid constituents, intended for use as a structural basis for further incorporation of biomolecules carrying out a function.
  • non-fragile polar-nonpolarpolarpolar membrane is one of the most important ones in contemporary biochemistry.
  • the applications of such membranes, once stable ones can be made, are numerous, and could be expected to speed up the development in fields of applied biochemistry in which the biological functions of molecular components are used artificially to generate transmembraneous electrical potentials, currents, and/or fluxes of lou molecular weight compounds.
  • One such example of a potentially useful transmembraneous gradient is the photo-mechanical energy conversion mediated by bacteriorhodopsin, in which case light is directly transformed into mechanical work (1).
  • Another category of examples would be in vitro correspondences to cases when the plasma membrane receptors upon binding the appropriate ligands bring about, directly or indirectly, a change of the trans-membraneous potentials.
  • the latter category of examples would include glucose receptors, glucose and amino acid transporters, membrane-bound immunoglobulins which are part of a trans-membrane potential -modulating system, receptors for growth factors, various ion channels and other carrier molecules.
  • glucose receptors glucose and amino acid transporters
  • membrane-bound immunoglobulins which are part of a trans-membrane potential -modulating system
  • receptors for growth factors various ion channels and other carrier molecules.
  • these examples are of considerable clinical and medical importance.
  • bioelectrici ty, biopotentials and/or biocurrents where biomolecules are used and where they have to be anchored, linked or bound to a polar-nonpolar-polar (PNP) membrane might be possible to concieve in the future.
  • PNP polar-nonpolar
  • biomolecules the function of which is linked to a PNP-membrane
  • the formation of such membranes is an extremely important topic in biochemistry.
  • any industrial applications of these biomolecules for example photomechanics photoosmotic or photoelectric energy conversion using bacteriorhodopsin, glucose receptor units for automatic control of glucose levels in, diabetic patients, or diagnostic equipment based on immunoreceptors linked to a PNP- -membrane, would depend on the type of PNP-membrane used.
  • any improvement, in any respect, of the formation of PNP-membranes has considerable industrial impact, as far as the further development of applications of PNP-membranes is concerned.
  • lipid bilayers The fragility of lipid bilayers is well known to researchers in the field and is primarily due to the fact that they mostly are stabilized in the plane parallel to the surface of the membrane by weak, or at least transient hydrophobic interactions, and by transient hydrogen bonds between the polar residues of the lipid. These conditions permit long range diffusion of the individual lipid molecules above the phase transition point, when the lipid is "liquid” or "fluid". Many attempts have been made and published previously to "cross-link” the lipid at its polar residues, binding it to polar, high molecular weight com pounds or surfaces. These attempts present the disadvantage that the short range interactions between the individual lipid molecules will have to adapt to any long range changes of the high molecular weight cross-linker or the surface.
  • the cross-linker or the surface expands or contracts on the long range scale, the covalently bound lipid will be forced to move in between its short range neighbours in the plane of the membrane and the lipid or any other molecules inserted into the membrane will be perturbed.
  • the physico-chemical properties of the surface or the cross-linker and, in particular, their expansion coefficients given in per cent change of length or area per unit change of any exterior conditions such as temperature, pH, ionic strength or composition, of the buffer may not be the same as those of the lipid bilayers.
  • Another disadvantage of using a long-range cross-linker or surface external to the lipid bilayer is that any transmembraneous events, such as fluxes and/or changes of electrical potential, will not easily be recorded, due to the presence of the extra diffusion barrier.
  • lipid bilayers when considered far medical use in the body is the tendency of such lipid to bind to other components present there. It is well known, for example, that lipid binds to albumin and the various lipoproteins present in plasma. Of course, this leads to that the lipid disappears from any structure where it would have been placed to form a membrane as soon as that structure is placed inside the body.
  • interphase peptides In the original theory of "interphase peptides" (2,3) it has been suggested that they are stabilized by hydrophohic contact with other peptides and/or lipid, which is in accordance with the so called “hydrophobic effect", and would thus seem to be thermodynamically possible. ("The hydrophobic effect” is a term denoting the finding that polar and nonpolar solvents form separate phases). In addition, it has been suggested (2,3) that interphase peptides are stabilized by hydrogen bonds and salt bridges. These features will allow the membrane to have many properties similar to those of lipid bilayers (3).
  • That interphase peptides are thermodynamically stable or, more precisely, in accordance with the hydrophobic effect means that according to the original theory, conditions would be possible to establish when they form spontaneously at a hydrophobic - hydrophilic interphase. Since hydrophobic interactions are predominantly van der Vaals interactions involving fluctuating dipole moments of almost equivalent nonpolar groups of adjacent micelles, the formation of an interphase peptide at a hydrophobic surface of a solid or at that of a liquid would not be expected to be qualitatively different from each other. However, due to the thermal agitation within a nonpolar liquid, it can be anticipated that the formation of an interphase peptide at such a boundary would take longer time than, at the boundary of a nonpolar solid.
  • the present invention describes a method to assemble a core structure of a membrane based on interactions between interphase peptides and lipid, without any claim regarding the detailed applications of such a membrane.
  • the method described will be possible to optimize.
  • many techniques have been published on how to incorporate functional proteins into lipid monolayers or lipid bilayers, and on the conditions which are suitable for this. Since the membrane described here is partly based on lipid, it can be anticipated that future attempts to incorporate functional proteins into it would rely, at least partly, on previous work on lipid monolayers or bilayers.
  • the interphase peptide is formed from a solution of poly-L-lysine (4-5 g/l), MW 15-30.000, or specifically 20- 25.000) in 0.4 M KOH at approximately OoC on top of which ethyl ether is layered.
  • the aqueous phase conditions are essentially those given in previously published experiments (4), the only difference being that the solid hydrophobic surface has been replaced by a liquid one. Since interphase peptides are thermodynamically stable (3), these conditions would not be critical, and other conditions suitable for the formation of interphase peptides would be possible to establish by any skilled experimentalist who has knowledge of the chemical and physical properties of the peptide at various pH values and for all ranges of molecular weights.
  • the incubation at approximately 0°C is continued until a layer of inter phase peptide is detectable, for example by visual inspection. This may require that the incubation at 0°C is continued for approximately a week, using the specified conditions. It is advisable to interrupt the incubation before the peptide is folded into the organic phase so that the membrane becomes rough on the nonpolar side. The conditions given are probably not the best for settling a stable interphase peptide and would be passible to optimize by modulating the ionic strength, the temperature, any other variable or the choice of organic solvent.
  • the experiments can be carried out such that one ml of organic solvent is layered on top of one ml of aqueous phase in a cylindrical glass vial of 9 mm diameter having a flat bottom.
  • a cylindrical tube On the bottom in the aqueous phase and below the phase boundary has been placed (before the solvent is added) a cylindrical tube the upper end onto which has been stretched and glued a porous supporting membrane and along one side of which has been attached a long glass capillary extending to the top of the glass vial to serve as a handle.
  • the tube should not be made from teflon or any other material which strongly adsorbs polylysine
  • the purpose of this devise is to lift the interphase membrane from below after it has formed and it should be devised in such a way that there is no vigorous movement of liquid in the aqueous phase below the membrane when it is lifted from the surface of the remaining liquid. It is desirable that the supporting membrane is smooth and that the pores in it are small since such conditions will decrease the probability that cracks appear in the interphase membrane when it is lifted. It is possible to avoid that the liquid inside the tube drops out of the tube when it is lifted, by making the lower end of the tube more narrow than its average inner diameter.
  • the present invention does not relate to the type of supporting membrane used and many choices are possible.
  • a most simple and readily available choice is the transparent membrane which is used in the household for protecting food and is known under various commercial names such as "gladwrap", "surround-wrap” or "handi-wrap".
  • This type of membrane may be chosen for the experiments and glued onto the above-mentioned tube with alkali-resistant glue after which it is perforated with a needle as sharp-pointed as possible. For further optimation, it is desirable to select membranes which are smooth and have smaller pores. If the interphase peptide is formed from an alkaline solution, the supporting membrane should be alkaliresistant.
  • the purpose ⁇ f using porous supporting membranes is that trans-membraneous events taking place across the interphase membrane will be possible to record using standard techniques.
  • the membrane or the devise which have been described are not optimal but merely a conveniant way for any handy person to lift a planar interphase membrane from a surface or an interphase. It is desirable to make the devise smaller since this will decrease the probability of cracks in the interphase membrane, but on the other hand, this might require that the whole process of lifting the membrane is performed using some standard micro-manipulator.
  • the tube has a diameter of 5 mm and a height of 8 mm.
  • One advantage of the devise that has been described is that the nonpolar part of the interphase membrane is exposed and can be sealed to any other similarly formed membrane, the nonpolar part of which is exposed. Due to the "hydrophobic effect", the two membranes, one of which contains interphase peptide, will bind to each other, this being the essential feature of the invention. Many other types of devises can also be imagined, which would accomplish the same thing.
  • a significant advantage of using ether in the method described, as compared to many other organic solvents is that it easily can be evaporated, leaving the hydrophobic part of the interphase open to air.
  • Another organic solvent which is not volatile could be expected to be more difficult to remove and might thicken the nonpolar part of any PNP-membrane of which it forms a constituent to the extent that it would be impossible for inserted functional molecu les to carry out any vectorial trans-membraneous function.
  • thermodynamically stable (cf. 3) interphase peptide are not altered if the choice of organic solvent is altered, as long as the solvent does not contain any amount of polar groups. Also the shape of the solvent molecules will be of importance and it is advisable to check each solvent for its suitability to bind the peptide.
  • the interphase peptide is incubated with lipid.
  • lipid is regarded in its widest sense, as a group of amphiphilic elongated compounds composed of at least one polar group at one end and at least one nonpolar group at the opposite end, which definition may include, for example certain detergents.
  • this is allowed for by incubating the peptide with lipid, which, according to the original theory, stabilizes the membrane by interacting with the peptide in the nonpolar plane, a plane of hydrogen bonding, and a plane of salt bridges (3). None of these interactions is a covalent bond, which allows a certain flexibility of movement of the compounds forming the membrane, similarly to the case of lipid bilayers.
  • the lipid is added in the organic phase either in a finite ul of chloroform - methanol or in a few ul of ether or in any other suitable solvent. If a heterogeneous mixture of lipid is used, many different kinds of interactions between the lipid and the protein will be possible and the chances are better that the pores between the amino acid units are filled out. However, any type of amphiphilic lipid capable of settling at the polar-nonpolar boundary will fill out the pores and improve the fitting between the various residues. It should be remembered that there is competition for the boundary by the peptide and the lipid and if too much lipid is added, it may completely replace the peptide.
  • a heterogenic mixture of lipid can, for example, be prepared by dissolving one egg yolk to a total volume of 100 ml in 10 mM potassium phosphate buffer, pH 7.4, containing 0.15 M of potassium chloride, mixing it with 100 ml of chloroform - methanol (2:1), then extracting 50 ml of this mixture with 100 ml of chloroform and filtering the organic phase through several (5) layers of filter paper so that it becomes clear.
  • the resulting clear organic phase can be used in the method described here.
  • the extraction of lipid from various raw materials has been well described in the literature and many other ways to prepare lipid are known.
  • lipid fractions containing less cholesterol than the one specified above can be obtained and used for the present invention.
  • the lipid is added to the organic phase after the interphase peptide has formed or while it is being formed, as long as it does not interfere with its formation. Using the conditions specified above, it is added to the organic phase after approximately 10 days of incubation with the poly-L-lysine, and the incubation at 0oC is then continued overnight. Excess lipid is then removed by carefully replacing the organic phase several times with pure ether.
  • ⁇ f lipid to the organic phase is convenient and preferrable to adding it in the aqueous phase, in which case it may form micelles and may not enter the boundary due to steric hindrance from the peptide or electrostatic factors.
  • whether the lipid is added from the aqueous phase or the organic phase is not critical for the present invention as long as it does not dissolve the interphase peptide into the polar or nonpolar phases.
  • lipid can be expected to fill out existing pores more or less efficiently and the method has yet to be optimized in this respect.
  • To make a stable membrane it is desirable to optimize the nonpolar interactions, the hydrogen bonding and the salt bridges within the membrane, as stated in the original theory (3).
  • a way of doing this is to select a heterogeneous mixture of lipid and expect that the best fitted lipid will settle at the boundary and that the final proteolipid boundary will represent the thermodynamically most stable condition, excluding un-fitted lipid species.
  • the interacting lipid species can be identified, they can be added specifically in well-defined amounts, but this will hardly affect the mechanisms of the formation of the proteolipid membrane, which is formed as a result of thermodynamic forces.
  • the thus formed proteolipid membrane is joined to a similarly formed proteolipid membrane which has been collected on another supporting membrane and another lifting devise ⁇ f the same type, in such a way that the nonpolar parts of the proteolipid membranes are brought into contact. It should be remembered that when the ether has evaporated, one important factor in keeping the proteolipid membrane together is lost and it is desirable to join the two membranes as soon as possible.
  • An advantage of the method of the invention which has been described is that the formed PNP-membrane will automatically be connected to two aqueous phase chambers which can be modified for further experimentation and optimation of the invention.
  • the two pieces of tube would be possible to prepare for various types of standard biochemical and biophysical experimentation.
  • they can be made in such a way that they seal tightly along the circumference after the PNP- membrane has formed, using, for example, a clamp mechanism.
  • the proteolipid membrane described here provides stabilization parallel to the plane of the membrane without any claim regarding the intactness of the membrane.
  • the membrane described may contain pores and/or cracks the amount of which may vary depending on the skill of the experimentalist. Therefore, the membrane should be regarded as a PNP-membrane with a predominantly nonpolar core and suitable for optimation of its sealing perpendicular to its plane, as well as of its stability parallel to the membrane.
  • the proteolipid membrane In addition to joining the proteolipid membrane to another similarly formed membrane, it can be joined to a lipid monolayer formed in a conventional way on the surface of an aqueous solution and pressed together to form as high a density of lipid per surface unit as possible.
  • the aqueous phase should have approximately the same ionic strength and pH as that on the polar side of the proteolipid membrane.
  • the PNP-membrane described in the method of the invention may be subject to limited proteolytic digestion after its formation. Then, the composition of the buffer should be such that it does not destabilize the membrane.

Abstract

A method for the formation of a proteolipid membrane based on interphase peptides according to which an interphase peptide which has formed at the boundary of an aqueous phase and a nonpolar phase of organic solvent is brought into contact with an assembly of amphiphilic compounds such that the nonpolar surfaces of the interphase peptide and of the assembly of amphiphilic compounds face each other. In addition to peptide, the membrane also contains lipid.

Description

Method for the assembly of polar-nonpolar-polar proteolipid membranes
This invention relates to the formation of a membrane from peptide and lipid constituents, intended for use as a structural basis far further incorporation of biomolecules carrying out a function.
The problem how to make a non-fragile polar-nonpolarpolar membrane is one of the most important ones in contemporary biochemistry. The applications of such membranes, once stable ones can be made, are numerous, and could be expected to speed up the development in fields of applied biochemistry in which the biological functions of molecular components are used artificially to generate transmembraneous electrical potentials, currents, and/or fluxes of low molecular weight compounds. One such example of a potentially useful transmembraneous gradient is the photo-mechanical energy conversion mediated by bacteriorhodopsin, in which case light is directly transformed into mechanical work (1). Another category of examples would be in vitro correspondances to cases when the plasma membrane receptors upon binding the appropriate ligands bring about, directly or indirectly, a change of the trans-membraneous potentials. The latter category of examples would include glucose receptors, glucose and amino acid transporters, membrane-bound immunoglobulins which are part of a trans-membrane potential -modulating system, receptors for growth factors, various ion channels and other carrier molecules. Obviously, these examples are of considerable clinical and medical importance. Furthermore, other applications of bioelectrici ty, biopotentials and/or biocurrertts, where biomolecules are used and where they have to be anchored, linked or bound to a polar-nonpolar-polar (PNP) membrane might be possible to concieve in the future. From the above-mentioned examples of biomolecules the function of which is linked to a PNP-membrane, it is obvious that the formation of such membranes is an extremely important topic in biochemistry. Furthermore, it is obvious that any industrial applications of these biomolecules, far example photomechanics photoosmotic or photoelectric energy conversion using bacteriorhodopsin, glucose receptor units for automatic control of glucose levels in diabetic patients, or diagnostic equipment based on immunoreceptors linked to a PNP- -membrane, would depend on the type of PNP-membrane used. For these reasons, any improvement, in any respect, of the formation of PNP-membranes has considerable industrial impact, as far as the further development of applications αf PNP-membranes is concerned.
The fragility of lipid bilayers is well known to researchers in the field and is primarily due to the fact that they mostly are stabilized in the plane parallel to the surface of the membrane by weak, or at least transient hydrophobic interactions, and by transient hydrogen bonds between the polar residues of the lipid. These conditions permit long range diffusion of the individual lipid molecules above the phase transition point, when the lipid is "liquid" or "fluid". Many attempts have been made and published previously to "cross-link" the lipid at its polar residues, binding it to polar, high molecular weight com pounds or surfaces. These attempts present the disadvantage that the short range interactions between the individual lipid molecules will have to adapt to any long range changes of the high molecular weight cross-linker or the surface. This means, for example, that if the cross-linker or the surface expands or contracts on the long range scale, the covalently bound lipid will be farced to move in between its short range neighbours in the plane of the membrane and the lipid or any other molecules inserted into the membrane will be perturbed. This follows naturally from that the physico-chemical properties of the surface or the cross-linker and, in particular, their expansion coefficients given in per cent change of length or area per unit change of any exterior conditions such as temperature, pH, ionic strength or composition of the buffer, may not. be the same as those of the lipid bilayers. Another disadvantage of using a long-range cross-linker or surface external to the lipid bilayer is that any transmembraneous events, such as fluxes and/or changes of electrical potential, will not easily be recorded, due to the presence of the extra diffusion barrier.
It is well known that many natural membranes are lipid bilayers and that the biological function of many molecular components can be recovered by inserting them into lipid bilayers. In some cases, this requires that certain lipid species are present or that the lipid is "fluid". There are many known methods of forming lipid bilayers which can be subject to experimentation, such as the sonication αf phospholipid, producing lipid vesicles, the formation of planar "black membranes" and the "patch clamp" technique for making a small area of bilayer membrane. As was mentioned above, the disadvantage of these techniques is the fragility of lipid bilayers, which becomes manifest as soon as a large area of membrane is to be assembled. Another disadvantage of pure lipid bilayers when considered far medical use in the body is the tendency of such lipid to bind to other components present there. It is well known, for example, that lipid binds to albumin and the various lipoproteins present in plasma. Of course, this leads to that the lipid disappears from any structure where it would have been placed to form a membrane as soon as that structure is placed inside the body.
From what has been mentioned above, it is obvious that it is desirable to search for an alternative to the lipid bilayer as a thin compartmentalizing PNP-membrane.
In contrast to the case of pure lipid bilayers, it has been suggested that biomembranes would exist which are stabilized by long-rangs covalent bonds and/or hydrogen bonds provided by amphiphilic "interphase peptides" which are shared by the hydrophilic and the hydrophobic phases of the boundary (2,3). The finding that certain peptides, notably poly-L-lysine, adheres to solid hydrophobic surfaces (4) provides experimental support that interphase peptides partitioning at the boundary between the hydrophilic and hydrophobic phases exist, whatever their secondary or tertiary configuration may be. (Poly-L-lysine is a highly hydrophilic substance, yet it binds to hydrophobic surfaces). In the original theory of "interphase peptides" (2,3) it has been suggested that they are stabilized by hydrophohic contact with other peptides and/or lipid, which is in accordance with the so called "hydr oph ob ic effect", and would thus seem to be thermodynamically possible. ("The hydrophobic effect" is a term denoting the finding that polar and nonpolar solvents form separate phases). In addition, it has been suggested (2,3) that interphase peptides are stabilized by hydrogen bonds and salt bridges. These features will allow the membrane to have many properties similar to those of lipid bilayers (3). That interphase peptides are thermodynamically stable or, more precisely, in accordance with the hydrophobic effect means that according to the original theory, conditions would be possible tα establish when they form spontaneously at a hydrophobic - hydrophilic interphase. Since hydrophobic interactions are predominantly van der Vaals interactions involving fluctuating dipole moments of almost equivalent nonpolar groups of adjacent micelles, the formation of an interphase peptide at a hydrophobic surface of a solid or at that αf a liquid would not be expected to be qualitatively different from each other. Howevsr, due to the thermal agitation within a nonpolar liquid, it can be anticipated that the formation of an interphase peptide at such a boundary would take longer time than at the boundary of a nonpolar solid.
From what has been said so far, briefly describing the state αf the art in the field of PNP-membranes and their industrial potential, it is obvious that present techniques need to be improved if the possible applications of such membranes are to be realized.
The present invention describes a method to assemble a core structure of a membrane based on interactions between interphase peptides and lipid, without any claim regarding the detailed applications of such a membrane. The method described will be passible to optimize. As for future applications of the method, many techniques have been published on how to incorporate functional proteins into lipid monolayers or lipid bilayers, and on the conditions which are suitable for this. Since the membrane described here is partly based on lipid, it can be anticipated that future attempts to incorporate functional proteins into it would rely, at least partly, on previous work on lipid monolayers or bilayers.
The interphase peptide is farmed from a solution of poly-L-lysine (4-5 g/l), MW 15-30.000, or specifically 20- 25.000) in 0.4 M KOH at approximately 0°C on top of which ethyl ether is layered. The aqueous phase conditions are essentially those given in previously published experiments (4), the only difference being that the solid hydrophobic surface has been replaced by a liquid one. Since interphase peptides are thermodynamically stable (3), these conditions would not be critical, and other conditions suitable for the formation αf interphase peptides would be possible to establish by any skilled experimentalist who has knowledge of the chemical and physical properties of the peptide at various pH values and for all ranges of molecular weights. The incubation at approximately 0ºC is continued until a layer of inter phase peptide is detectable, for example by visual inspection. This may require that the incubation at 0°C is continued far approximately a week, using the specified conditions. It is advisable to interrupt the incubation before the peptide is folded into the organic phase so that the membrane becomes rough on the nonpolar side. The conditions given are probably not the best far settling a stable interphase peptide and would be possible to optimize by modulating the ionic strength, the temperature, any other variable or the choice of organic solvent.
The experiments can be carried out such that one ml of organic solvent is layered on top of one ml of aqueous phase in a cylindrical glass vial of 9 mm diameter having a flat bottom. On the bottom in the aqueous phase and below the phase boundary has been placed (before the solvent is added) a cylindrical tube the upp er end onto wh ich has been stretched and glued a por ou s supporting membrane and along one side of which has been attached a long glass capillary extending to the top of the glass vial to serve as a handle. The tube should not be made from teflon or any other material which strongly adsorbs palylysine The purpose of this devise is to lift the interphase membrane from below after it has formed and it should be devised in such a way that there is no vigorous movement of liquid in the aqueous phase below the membrane when it is lifted from the surface of the remaining liquid. It is desirable that the supporting membrane is smooth and that the pores in it are small since such conditions will decrease the probability that cracks appear in the interphase membrane when it is lifted. It is possible to avoid that the liquid inside the tube drops out of the tube when it is lifted, by making the lower end of the tube more narrow than its average inner diameter.
The present invention does not relate to the type of supporting membrane used and many choices are possible. A most simple and readily available choice is the transparent membrane which is used in the household for protecting food and is known under various commercial names such as "gladwrap", "surround-wrap" or "handi-wrap". This type of membrane may be chosen far the experiments and glued onto the above-mentioned tube with alkali-resistant glue after which it is perforated with a needle as sharp-pointed as possible. Far further aptimation, it is desirable to select membranes which are smooth and have smaller pores. If the interphase peptide is formed from an alkaline solution, the supporting membrane should be alkaliresistant. The purpose αf using porous supporting membranes is that trans-membraneous events taking place across the interphase membrane will be passible to record using standard techniques.
The membrane or the devise which have been described are not optimal but merely a conveniant way for any handy person to lift a planar interphase membrane from a surface or an interphase. It is desirable to make the devise smaller since this will decrease the probability of cracks in the interphase membrane, but on the other hand, this might require that the whole process of lifting the membrane is performed using some standard micro-manipulator. As described above, the tube has a diameter of 5 mm and a height of 8 mm. One advantage of the devise that has been described is that the nonpolar part of the interphase membrane is exposed and can be sealed to any other similarly formed membrane, the nonpolar part of which is exposed. Due to the "hydrophobic effect", the two membranes, one of which contains interphase peptide, will bind to each other, this being the essential feature of the invention. Many other types of devises can also be imagined, which would accomplish the same thing.
In addition to poly-L-lysine, it is concievable that other peptides having the property of forming an interphase boundary exist or will be discovered in the future. The present invention would be applicable irrespective of type or molecular weight of the interphase peptide, although in each particular case, the optimal experimental conditions would be expected to be different. A necessary condition would, of course, be that any significant amount αf interphase peptide is formed and that some of it stays at the boundary ( or the surface of the aqueous phase) during subsequent experimental steps.
A significant advantage of using ether in the method described, as compared to many other organic solvents is that it easily can be evaporated, leaving the hydrophobic part of the interphase open to air. Another organic solvent which is not volatile could be expected to be more difficult to remove and might thicken the nonpolar part of any PNP-membrane of which it forms a constituent to the extent that it would be impossible for inserted functional molecu les to carry out any vectorial trans-membraneous function. However, it uould be possible tα use other organic solvents if they can be replaced with a volatile solvent after the interphase peptide has formed. This follows from the near equivalence of hydrophobic bonding, which involves fluctuating dipole moments (van der Vaals forces) irrespective of the chemical composition of the compound. Therefore, it is obvious that the basic mechanisms of the formation of a thermodynamically stable (cf. 3) interphase peptide are not altered if the choice of organic solvent is altered, as long as the solvent does not contain any amount of polar groups. Also the shape of the solvent molecules will be of importance and it is advisable to check each solvent for its suitability to bind the peptide.
According to the present invention, the interphase peptide is incubated with lipid. In this context, lipid is regarded in its widest sense, as a group of amphiphilic elongated compounds composed of at least one polar group at one end and at least one nonpolar group at the apposite end, which definition may include, for example certain detergents.
The rationale far incubating the peptide with lipid is that the spreading of the interphase configuration in the plane of the boundary between the nonpolar and polar phases is restricted by the constraints αf the possible angles of covalent bonding and it is expected that a membrane based solely on peptide would be porous. Furthermore, the binding blocks of the peptide are considerably larger than those of lipid monomers in lipid bilayers, and tight fitting between the peptide building blocks down to the atomic level can not be anticipated. In the original theory of membranes based on interphase peptides (2, 3), the membranes are stabilized not only by hydrophobic interactions but also by the more specific hydrogen bonds and salt bridges. According to the present invention, this is allowed for by incubating the peptide with lipid, which, according to the original theory, stabilizes the membrane by interacting with the peptide in the nonpolar plane, a plane of hydrogen bonding, and a plane of salt bridges (3). None αf these interactions is a covalent bond, which allows a certain flexibility of movement of the compounds forming the membrane, similarly to the case of lipid bilayers.
The lipid is added in the organic phase either in a few ul of chloroform - methanol or in a few ul αf ether or in any other suitable solvent. If a heterogeneous mixture of lipid is used, many different kinds of interactions between the lipid and the protein will be passible and the chances are better that the pores between the amino acid units are filled out. However, any type of amphiphilic lipid capable of settling at the poIar-nonpolar boundary will fill out the pores and improve the fitting between the various residues. It should be remembered that there is competition for the boundary by the peptide and the lipid and if too much lipid is added, it may completely replace the peptide. A heterogenic mixture of lipid can, for example, be prepared by dissolving one egg yolk to a total volume of 100 ml in 10 mM potassium phosphate buffer, pH 7.4, containing 0.15 M of potassium chloride, mixing it with 100 ml of chloroform - methanol (2:1), then extracting 50 ml of this mixture with 100 ml of chloroform and filtering the organic phase through several (5) layers of filter paper so that it becomes clear. The resulting clear organic phase can be used in the method described here. However, the extraction of lipid from various raw materials has been well described in the literature and many other ways to prepare lipid are known. In particular, lipid fractions containing less cholesterol than the one specified above can be obtained and used for the present invention.
The lipid is added to the organic phase after the interphase peptide has formed αr while it is being formed, as long as it does not interfere with its formation. Using the conditions specified above, it is added to the organic phase after approximately 10 days of incubation with the paly-L-lysine, and the incubation at 0°C is then continued overnight. Excess lipid is then removed by carefully replacing the organic phase several times with pure ether.
The addition of lipid tα the organic phase is convenient, and preferrable to adding it in the aqueous phase, in which case it may form micelles and may not enter the boundary due to steric hindrance from the peptide or electrostatic factors. However, whether the lipid is added from the aqueous phase or the organic phase is not critical for the present invention as long as it does not dissolve the interphase peptide into the polar or nonpolar phases.
Various types of lipid can be expected to fill out existing pores more or less efficiently and the method has yet to be optimized in this respect. To make a stable membrane, it is desirable to optimize the nonpolar interactions, the hydrogen bonding and the salt bridges within the membrane, as stated in the original theory (3). A way of doing this is to select a heterogeneous mixture of lipid and expect that the best fitted lipid will settle at the boundary and that the final proteolipid boundary will represent the thermodynamically most stable condition, excluding un-fitted lipid species. Of course, once the interacting lipid species can be identified, they can be added specifically in well-defined amounts, but this will hardly affect the mechanisms of the formation of the proteolipid membrane, which is formed as a result of thermodynamic farces.
After formation of the proteolipid membrane, excess organic solvent is evaporated or aspirated, leaving the interphase under the meniscus, and the proteolipid membrane is lifted put of the incubation vessel. This should be done in a cold room, preferrably keeping 0°C - - 2°C. In one realization αf the invention, the thus formed proteolipid membrane is joined to a similarly formed proteolipid membrane which has been collected on another supporting membrane and another lifting devise of the same type, in such a way that the nonpolar parts of the proteolipid membranes are brought into contact. It should be remembered that when the ether has evaporated, one important factor in keeping the proteolipid membrane together is lost and it is desirable to join the two membranes as soon as possible. On the other hand, if there is still a significant amount of organic solvent on the nonpolar side of any of the two proteolipid membranes, it will be included in the PNP-membrane and make it thicker. If, subsequently, the organic solvent is equilibrated out of the membrane, the latter may be perturbed.
An advantage of the method of the invention which has been described is that the formed PNP-membrane will automatically be connected. to two aqueous phase chambers which can be modified far further experimentation and optimation of the invention. The two pieces of tube would be possible to prepare for various types of standard biochemical and biophysical experimentation. In particular, they can be made in such a way that they seal tightly along the circumference after the PNP- membrane has formed, using, for example, a clamp mechanism.
However, many other methods to join a peptide (-lipid) membrane to an assembly of amphiphilic compounds, which is an essential feature of the invention, can be imagined. The advantage of a PNP-membrane in which interphase peptides form an essential part, according to the method described, as compared to lipid bilayers, is that the membrane containing interphase peptides is stabilized in the plane parallel tα its surface by covalent bonds which extend continuously for a longer distance than the average diameter of the lipid of lipid bilayers. This is a requirement for the poly-L-lysine to partition at the boundary of a nonpolar surface, as it is known to do (4) and is evident far the naked eye in the method described by the high viscosity of the interphase membrane based on peptide as opposed to that of an interphase based on the described lipid mixture (added in chloroform-methanol) only. In the farmer case, any irregularities or particles at the interphase will retain their approximate relative location even if the glass vial is gently agitated by hand. This clearly shows th t there is long range structure in the plane cf the membrane bordering the nonpolar phase when the peptide is there as opposed to the case when only lipid has access to the boundary between the polar and nonpolar phases. when the nonpolar phase is subsequently replaced with another membrane such that the two membranes are joined by hydrophobic bonding, this state of facts is, due to the near equivalence of hydrophobic banding irrespective of chemical compound, not qualitatively changed. The advantage of an interphase peptide providing long-range structure in the form αf covalent bonds extending parallel to the plane of the membrane is, of course, that it will stabilize the whole membrane by providing permanent covalent bonds instead of transient hydrophobic bonding or hydrogen bonding. Above the melting point of the lipid, when the latter is "fluid" or "liquid" and tends to diffuse away in any lipid bilayer structure where it is a constituent, such stabilization by covalent bonds would be particularly important for maintaining a structure in the plane of the membrane.
Thus, while the lipid bilayer is appreciated for its tight sealing perpendicular to the plane of the membrane, the proteolipid membrane described here provides stabilization parallel to the plane of the membrane without any claim regarding the intactness of the membrane. The membrane described may contain pores and/or cracks the amount of which may vary depending on the skill of the experimentalist. Therefore, the membrane should be regarded as a PNP-membrane with a predominantly nonpolar core and suitable for optimation of its sealing perpendicular to its plane, as well as of its stability parallel tα the membrane.
In addition tα joining the proteolipid membrane to another similarly formed membrane, it can be joined to a lipid monolayer formed in a conventional way an the surface of an aqueous solution and pressed together to form as high a density αf lipid per surface unit as possible. The aqueous phase should have approximately the same ionic strength and pH as that on the polar side of the proteolipid membrane. The joining together of a proteolipid membrane as described with a conventional lipid monolayer such that their nonpolar surfaces face each other follows the same principles (the hydrophobic effect) as does the joining together of two proteolipid membranes as described previously.
The PNP-membrane described in the method of the invention may be subject to limited proteolytic digestion after its formation. Then, the composition of the buffer should be such that it does not destabilize the membrane.
References
1. R.C. Srivastava et. al.: Experientia 40 (7), 773-775
(1984) 2. E. Cervén: Upsala J. Med. Sci. 81, 193-200 (1976) 3. E. Cervén: Upsala J. Med . Sci. 82, 167-181 (1977) 4. S.S. Brown : Piethods in Cell Biology. Vol 24, Pt. A
(Ed: L. Wilson), pp 291-300, Academic Press, New York,
London, Paris, San Diego, San Fransisco, Sao Paulo,
Sydney, Tokyo, Toronto (1982)
Figure imgf000025_0001
Figure imgf000026_0001
Method for the assembly of polar-nonpolar-polar proteolipid membranes
This invention, relates to the formation of a membrane from peptide and lipid constituents, intended for use as a structural basis for further incorporation of biomolecules carrying out a function.
The problem how to make a non-fragile polar-nonpolarpolar membrane is one of the most important ones in contemporary biochemistry. The applications of such membranes, once stable ones can be made, are numerous, and could be expected to speed up the development in fields of applied biochemistry in which the biological functions of molecular components are used artificially to generate transmembraneous electrical potentials, currents, and/or fluxes of lou molecular weight compounds. One such example of a potentially useful transmembraneous gradient is the photo-mechanical energy conversion mediated by bacteriorhodopsin, in which case light is directly transformed into mechanical work (1). Another category of examples would be in vitro correspondences to cases when the plasma membrane receptors upon binding the appropriate ligands bring about, directly or indirectly, a change of the trans-membraneous potentials. The latter category of examples would include glucose receptors, glucose and amino acid transporters, membrane-bound immunoglobulins which are part of a trans-membrane potential -modulating system, receptors for growth factors, various ion channels and other carrier molecules. Obviously, these examples are of considerable clinical and medical importance. Furthermore, other applications of bioelectrici ty, biopotentials and/or biocurrents, where biomolecules are used and where they have to be anchored, linked or bound to a polar-nonpolar-polar (PNP) membrane might be possible to concieve in the future. From the above-mentioned examples of biomolecules the function of which is linked to a PNP-membrane, it is obvious that the formation of such membranes is an extremely important topic in biochemistry. Furthermore, it is obvious that any industrial applications of these biomolecules, for example photomechanics photoosmotic or photoelectric energy conversion using bacteriorhodopsin, glucose receptor units for automatic control of glucose levels in, diabetic patients, or diagnostic equipment based on immunoreceptors linked to a PNP- -membrane, would depend on the type of PNP-membrane used. For these reasons, any improvement, in any respect, of the formation of PNP-membranes has considerable industrial impact, as far as the further development of applications of PNP-membranes is concerned.
The fragility of lipid bilayers is well known to researchers in the field and is primarily due to the fact that they mostly are stabilized in the plane parallel to the surface of the membrane by weak, or at least transient hydrophobic interactions, and by transient hydrogen bonds between the polar residues of the lipid. These conditions permit long range diffusion of the individual lipid molecules above the phase transition point, when the lipid is "liquid" or "fluid". Many attempts have been made and published previously to "cross-link" the lipid at its polar residues, binding it to polar, high molecular weight com pounds or surfaces. These attempts present the disadvantage that the short range interactions between the individual lipid molecules will have to adapt to any long range changes of the high molecular weight cross-linker or the surface. This means, for example,, that if the cross-linker or the surface expands or contracts on the long range scale, the covalently bound lipid will be forced to move in between its short range neighbours in the plane of the membrane and the lipid or any other molecules inserted into the membrane will be perturbed. This follows naturally from that the physico-chemical properties of the surface or the cross-linker and, in particular, their expansion coefficients given in per cent change of length or area per unit change of any exterior conditions such as temperature, pH, ionic strength or composition, of the buffer, may not be the same as those of the lipid bilayers. Another disadvantage of using a long-range cross-linker or surface external to the lipid bilayer is that any transmembraneous events, such as fluxes and/or changes of electrical potential, will not easily be recorded, due to the presence of the extra diffusion barrier.
It is well knoun that many natural membranes are lipid bilayers and that the biological function of many molecular components can be recovered by inserting them into lipid bilayers. In some cases, this requires that certain lipid species are present or that the lipid is "fluid". There are many known methods of forming lipid bilayers which can be subject to experimentation, such as the sonication of phospholipid, producing lipid vesicles, the formation of planar "black membranes" and the "patch clamp" technique for making a small area of bilayer membrane. As was mentioned above, the disadvantage of these techniques is the fragility of lipid bilayers, which becomes manifest as soon as a large area of membrane is to be assembled. Another disadvantage of pure lipid bilayers when considered far medical use in the body is the tendency of such lipid to bind to other components present there. It is well known, for example, that lipid binds to albumin and the various lipoproteins present in plasma. Of course, this leads to that the lipid disappears from any structure where it would have been placed to form a membrane as soon as that structure is placed inside the body.
From what has been mentioned above, it is obvious that it is desirable to search for an alternative to the lipid bilayer as a thin compartmentalizing PNP-membrane.
In contrast to the case of pure lipid bilayers, it has been suggested that biomembranes would exist which are stabilized by long-range covalent bonds and/or hydrogen bonds provided by amphiphilic "interphase peptides" which are shared by the hydrophilic and the hydrophobic phases of the boundary (2,3). The finding that certain peptides, notably poly-L-lysine, adheres to solid hydrophobic surfaces (4) provides experimental support that interphase peptides partitioning at the houndary between the hydrophilic and hydrophobic phases exist, whatever their secondary or tertiary configuration may be. (Poly-L-lysine is a highly hydrophilic substance, yet it binds to hydrophobic surfaces). In the original theory of "interphase peptides" (2,3) it has been suggested that they are stabilized by hydrophohic contact with other peptides and/or lipid, which is in accordance with the so called "hydrophobic effect", and would thus seem to be thermodynamically possible. ("The hydrophobic effect" is a term denoting the finding that polar and nonpolar solvents form separate phases). In addition, it has been suggested (2,3) that interphase peptides are stabilized by hydrogen bonds and salt bridges. These features will allow the membrane to have many properties similar to those of lipid bilayers (3). That interphase peptides are thermodynamically stable or, more precisely, in accordance with the hydrophobic effect means that according to the original theory, conditions would be possible to establish when they form spontaneously at a hydrophobic - hydrophilic interphase. Since hydrophobic interactions are predominantly van der Vaals interactions involving fluctuating dipole moments of almost equivalent nonpolar groups of adjacent micelles, the formation of an interphase peptide at a hydrophobic surface of a solid or at that of a liquid would not be expected to be qualitatively different from each other. However, due to the thermal agitation within a nonpolar liquid, it can be anticipated that the formation of an interphase peptide at such a boundary would take longer time than, at the boundary of a nonpolar solid.
From what has been said so far, briefly describing the state of the art in the field of PNP-membranes and their industrial potential, it is obvious that present techniques need to be improved if the possible applications of such membranes are to be realized.
The present invention describes a method to assemble a core structure of a membrane based on interactions between interphase peptides and lipid, without any claim regarding the detailed applications of such a membrane. The method described will be possible to optimize. As for future applications of the method, many techniques have been published on how to incorporate functional proteins into lipid monolayers or lipid bilayers, and on the conditions which are suitable for this. Since the membrane described here is partly based on lipid, it can be anticipated that future attempts to incorporate functional proteins into it would rely, at least partly, on previous work on lipid monolayers or bilayers.
The interphase peptide is formed from a solution of poly-L-lysine (4-5 g/l), MW 15-30.000, or specifically 20- 25.000) in 0.4 M KOH at approximately OºC on top of which ethyl ether is layered. The aqueous phase conditions are essentially those given in previously published experiments (4), the only difference being that the solid hydrophobic surface has been replaced by a liquid one. Since interphase peptides are thermodynamically stable (3), these conditions would not be critical, and other conditions suitable for the formation of interphase peptides would be possible to establish by any skilled experimentalist who has knowledge of the chemical and physical properties of the peptide at various pH values and for all ranges of molecular weights. The incubation at approximately 0°C is continued until a layer of inter phase peptide is detectable, for example by visual inspection. This may require that the incubation at 0°C is continued for approximately a week, using the specified conditions. It is advisable to interrupt the incubation before the peptide is folded into the organic phase so that the membrane becomes rough on the nonpolar side. The conditions given are probably not the best for settling a stable interphase peptide and would be passible to optimize by modulating the ionic strength, the temperature, any other variable or the choice of organic solvent.
The experiments can be carried out such that one ml of organic solvent is layered on top of one ml of aqueous phase in a cylindrical glass vial of 9 mm diameter having a flat bottom. On the bottom in the aqueous phase and below the phase boundary has been placed (before the solvent is added) a cylindrical tube the upper end onto which has been stretched and glued a porous supporting membrane and along one side of which has been attached a long glass capillary extending to the top of the glass vial to serve as a handle. The tube should not be made from teflon or any other material which strongly adsorbs polylysine The purpose of this devise is to lift the interphase membrane from below after it has formed and it should be devised in such a way that there is no vigorous movement of liquid in the aqueous phase below the membrane when it is lifted from the surface of the remaining liquid. It is desirable that the supporting membrane is smooth and that the pores in it are small since such conditions will decrease the probability that cracks appear in the interphase membrane when it is lifted. It is possible to avoid that the liquid inside the tube drops out of the tube when it is lifted, by making the lower end of the tube more narrow than its average inner diameter.
The present invention does not relate to the type of supporting membrane used and many choices are possible. A most simple and readily available choice is the transparent membrane which is used in the household for protecting food and is known under various commercial names such as "gladwrap", "surround-wrap" or "handi-wrap". This type of membrane may be chosen for the experiments and glued onto the above-mentioned tube with alkali-resistant glue after which it is perforated with a needle as sharp-pointed as possible. For further optimation, it is desirable to select membranes which are smooth and have smaller pores. If the interphase peptide is formed from an alkaline solution, the supporting membrane should be alkaliresistant. The purpose αf using porous supporting membranes is that trans-membraneous events taking place across the interphase membrane will be possible to record using standard techniques.
The membrane or the devise which have been described are not optimal but merely a conveniant way for any handy person to lift a planar interphase membrane from a surface or an interphase. It is desirable to make the devise smaller since this will decrease the probability of cracks in the interphase membrane, but on the other hand, this might require that the whole process of lifting the membrane is performed using some standard micro-manipulator. As described above, the tube has a diameter of 5 mm and a height of 8 mm. One advantage of the devise that has been described is that the nonpolar part of the interphase membrane is exposed and can be sealed to any other similarly formed membrane, the nonpolar part of which is exposed. Due to the "hydrophobic effect", the two membranes, one of which contains interphase peptide, will bind to each other, this being the essential feature of the invention. Many other types of devises can also be imagined, which would accomplish the same thing.
In addition to poly-L-Iysine, it is concievable that other peptides having the property of forming an interphase boundary exist or will be discovered in the future. The present invention would be applicable irrespective of type or molecular weight of the interphase peptide, although in each particular case, the optimal experimental conditions would be expected to be different. A necessary condition would, of course, be that any significant amount αf interphase peptide is formed and that some of it stays at the boundary (or the surface of the aqueous phase) during subsequent experimental steps.
A significant advantage of using ether in the method described, as compared to many other organic solvents is that it easily can be evaporated, leaving the hydrophobic part of the interphase open to air. Another organic solvent which is not volatile could be expected to be more difficult to remove and might thicken the nonpolar part of any PNP-membrane of which it forms a constituent to the extent that it would be impossible for inserted functional molecu les to carry out any vectorial trans-membraneous function. However, it would be possible to use other organic solvents if they can be replaced with a volatile solvent after the interphase peptide has formed. This follows from the near equivalence of hydrophobic bonding, which involves fluctuating dipole moments (van der Vaals forces) irrespective of the chemical composition of the compound. Therefore, it is obvious that the basic mechanisms of the formation of a thermodynamically stable (cf. 3) interphase peptide are not altered if the choice of organic solvent is altered, as long as the solvent does not contain any amount of polar groups. Also the shape of the solvent molecules will be of importance and it is advisable to check each solvent for its suitability to bind the peptide.
According to the present invention, the interphase peptide is incubated with lipid. In this context, lipid is regarded in its widest sense, as a group of amphiphilic elongated compounds composed of at least one polar group at one end and at least one nonpolar group at the opposite end, which definition may include, for example certain detergents.
The rationale for incubating the peptide with lipid is that the spreading αf the interphase configuration in the plane of the boundary between the nonpolar and polar phases is restricted by the constraints of the possible angles of covalent bonding and it is expected that a membrane based solely on peptide would be porous. Furthermore, the binding blocks of the peptide are considerably larger than those of lipid monomers in lipid bilayers, and tight fitting between the peptide building blocks down to the atomic level can not be anticipated. In the original theory of membranes based on interphase peptides (2, 3), the membranes are stabilized not only by hydrαphobic interactions but also by the more specific hydrogen bands and salt bridges. According to the present invention, this is allowed for by incubating the peptide with lipid, which, according to the original theory, stabilizes the membrane by interacting with the peptide in the nonpolar plane, a plane of hydrogen bonding, and a plane of salt bridges (3). None of these interactions is a covalent bond, which allows a certain flexibility of movement of the compounds forming the membrane, similarly to the case of lipid bilayers.
The lipid is added in the organic phase either in a feu ul of chloroform - methanol or in a few ul of ether or in any other suitable solvent. If a heterogeneous mixture of lipid is used, many different kinds of interactions between the lipid and the protein will be possible and the chances are better that the pores between the amino acid units are filled out. However, any type of amphiphilic lipid capable of settling at the polar-nonpolar boundary will fill out the pores and improve the fitting between the various residues. It should be remembered that there is competition for the boundary by the peptide and the lipid and if too much lipid is added, it may completely replace the peptide. A heterogenic mixture of lipid can, for example, be prepared by dissolving one egg yolk to a total volume of 100 ml in 10 mM potassium phosphate buffer, pH 7.4, containing 0.15 M of potassium chloride, mixing it with 100 ml of chloroform - methanol (2:1), then extracting 50 ml of this mixture with 100 ml of chloroform and filtering the organic phase through several (5) layers of filter paper so that it becomes clear. The resulting clear organic phase can be used in the method described here. However, the extraction of lipid from various raw materials has been well described in the literature and many other ways to prepare lipid are known. In particular, lipid fractions containing less cholesterol than the one specified above can be obtained and used for the present invention.
The lipid is added to the organic phase after the interphase peptide has formed or while it is being formed, as long as it does not interfere with its formation. Using the conditions specified above, it is added to the organic phase after approximately 10 days of incubation with the poly-L-lysine, and the incubation at 0ºC is then continued overnight. Excess lipid is then removed by carefully replacing the organic phase several times with pure ether.
The addition αf lipid to the organic phase is convenient and preferrable to adding it in the aqueous phase, in which case it may form micelles and may not enter the boundary due to steric hindrance from the peptide or electrostatic factors. However, whether the lipid is added from the aqueous phase or the organic phase is not critical for the present invention as long as it does not dissolve the interphase peptide into the polar or nonpolar phases.
Various types of lipid can be expected to fill out existing pores more or less efficiently and the method has yet to be optimized in this respect. To make a stable membrane, it is desirable to optimize the nonpolar interactions, the hydrogen bonding and the salt bridges within the membrane, as stated in the original theory (3). A way of doing this is to select a heterogeneous mixture of lipid and expect that the best fitted lipid will settle at the boundary and that the final proteolipid boundary will represent the thermodynamically most stable condition, excluding un-fitted lipid species. Of course, once the interacting lipid species can be identified, they can be added specifically in well-defined amounts, but this will hardly affect the mechanisms of the formation of the proteolipid membrane, which is formed as a result of thermodynamic forces.
After formation of the proteolipid membrane, excess organic solvent is evaporated or aspirated, leaving the interphase under the meniscus, and the proteolipid membrane is lifted out of the incubation vessel. This should be done in a cold room, preferrably keeping 0°C - - 2°C. In one realization of the invention, the thus formed proteolipid membrane is joined to a similarly formed proteolipid membrane which has been collected on another supporting membrane and another lifting devise αf the same type, in such a way that the nonpolar parts of the proteolipid membranes are brought into contact. It should be remembered that when the ether has evaporated, one important factor in keeping the proteolipid membrane together is lost and it is desirable to join the two membranes as soon as possible. On the other hand, if there is still a significant amount αf organic solvent on the nonpolar side of any of the two proteolipid membranes, it will be included in the PNP-membrane and make it thicker. If, subsequently, the organic solvent is equilibrated out αf the membrane, the latter may be perturbed.
An advantage of the method of the invention which has been described is that the formed PNP-membrane will automatically be connected to two aqueous phase chambers which can be modified for further experimentation and optimation of the invention. The two pieces of tube would be possible to prepare for various types of standard biochemical and biophysical experimentation. In particular, they can be made in such a way that they seal tightly along the circumference after the PNP- membrane has formed, using, for example, a clamp mechanism.
However, many other methods to join a peptide (-lipid) membrane to an assembly of amphiphilic compounds, which is an essential feature of the invention, can be imagined. The advantage of a PNP-membrane in which interphase peptides form an essential part, according to the method described, as compared to lipid bilayers, is that the membrane containing interphase peptides is stabilized in the plane parallel to its surface by covalent bonds which extend continuously for a longer distance than the average diameter of the lipid of lipid bilayers. This is a requirement for the poly-L-lysine to partition at the boundary of a nonpolar surface, as it is known to do (4) and is evident far the naked eye in the method described by the high viscosity of the interphase membrane based an peptide as opposed to that of an interphase based on the described lipid mixture (added in chloroform-methanol) only. In the former case, any irregularities or particles at the interphase will retain their approximate relative location even if the glass vial is gently agitated by hand. This clearly shows th t there is long range structure in the plane of the membrane bordering the nonpolar phase when the peptide is there as opposed to the case when only lipid has access to the boundary between the polar and nonpolar phases. When the nonpolar phase is subsequently replaced with another membrane such that the two membranes are joined by hydrophobic bonding, this state of facts is, due to the near equivalence of hydrophobic bonding irrespective of chemical compound, not qualitatively changed. The advantage of an interphase peptide providing long-range structure in the form of covalent bonds extending parallel to the plane of the membrane is, of course, that it will stabilize the whole membrane by providing permanent covalent bonds instead of transient hydrophobic bonding or hydrogen bonding. Above the melting paint of the lipid, when the latter is "fluid" or "liquid" and tends to diffuse away in any lipid bilayer structure where it is a constituent, such stabilization by covalent bonds would be particularly important for maintaining a structure in the plane of the membrane.
Thus, while the lipid bilayer is appreciated for its tight sealing perpendicular to the plane of the membrane, the proteolipid membrane described here provides stabilization parallel to the plane of the membrane without any claim regarding the intactness of the membrane. The membrane described may contain pores and/or cracks the amount of which may vary depending on the skill of the experimentalist. Therefore, the membrane should be regarded as a PNP-membrane with a predominantly nonpolar core and suitable for optimation of its sealing perpendicular to its plane, as well as of its stability parallel to the membrane.
In addition to joining the proteolipid membrane to another similarly formed membrane, it can be joined to a lipid monolayer formed in a conventional way on the surface of an aqueous solution and pressed together to form as high a density of lipid per surface unit as possible. The aqueous phase should have approximately the same ionic strength and pH as that on the polar side of the proteolipid membrane. The joining together of a proteolipid membrane as described with a conventional lipid monolayer such that their nonpolar surfaces face each other follows the same principles (the hydrophobic effect) as does the joining together of two proteolipid membranes as described previously.
The PNP-membrane described in the method of the invention may be subject to limited proteolytic digestion after its formation. Then, the composition of the buffer should be such that it does not destabilize the membrane.
References
1. R.C. Srivastava et. al.: Experientia 40 (7), 773-775 (1984)
2. E. Cervén: Upsala J. Med.Sci. 81, 193-200 (1976)
3. E. Cervén: Upsala J. Med. Sci. 82, 167-181 (1977)
4. S.S. Brown : Methods in Cell Biology. Vol 24, Pt. A (Ed: L. Wilson), pp 291-300, Academic Press, New York, London, Paris, San Diego, San Fransisco, Sao Paulo, Sydney, Tokyo, Toronto (1982)

Claims

1. A method for the assembly of a polar-nonpolar-polar proteolipid membrane according to which an interphase peptide which has been formed at the boundary between an aqueous phase and a nonpolar phase of organic solvent is brought into physical contact with an assembly of amphiphilic molecules forming a surface, in such a way that the nonpolar surfaces of the interphase peptide and of the assembly of amphiphilic molecules face each other.
2. A method as claimed in claim 1, wherein the interphase peptide has been incubated with lipid.
3. A method as claimed in claim 2, wherein the lipid is a mixture of lipid species.
4. A method as claimed in any preceding claim, wherein the interphase peptide has been derived from poly-L-lysine and the lipid from egg yolk.
PCT/SE1986/000563 1985-12-10 1986-12-10 Method for the assembly of polar-nonpolar-polar proteolipid membranes WO1987003509A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ214495A NZ214495A (en) 1985-12-10 1985-12-10 Formation of polar-nonpolar-polar proteolipid membranes
NZ214495 1985-12-10

Publications (1)

Publication Number Publication Date
WO1987003509A1 true WO1987003509A1 (en) 1987-06-18

Family

ID=19921489

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1986/000563 WO1987003509A1 (en) 1985-12-10 1986-12-10 Method for the assembly of polar-nonpolar-polar proteolipid membranes

Country Status (5)

Country Link
US (1) US5080936A (en)
EP (1) EP0248877A1 (en)
AU (1) AU6738787A (en)
NZ (1) NZ214495A (en)
WO (1) WO1987003509A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992016209A1 (en) * 1991-03-14 1992-10-01 Reanal Finomvegyszergyár Granules and veterinary compositions comprising a water-soluble complex of flumequine

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE161287T1 (en) * 1992-03-23 1998-01-15 Siemens Ag IMMOBILIZATION OF BIOCHEMICAL SUBSTANCES
US5670483A (en) * 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US6916488B1 (en) 1999-11-05 2005-07-12 Biocure, Inc. Amphiphilic polymeric vesicles
AU2001264623A1 (en) 2000-05-16 2001-11-26 Biocure, Inc. Membranes formed from amphiphilic copolymers
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN115007004B (en) * 2022-05-16 2023-12-26 天津工业大学 Preparation method of hydrophilic charged high-voltage reverse osmosis membrane based on egg albumin/aromatic polyamide

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3736204A (en) * 1969-08-08 1973-05-29 American Cyanamid Co Reverse osmotic water purification
US3892665A (en) * 1973-10-15 1975-07-01 Standard Oil Co Membrane method and product
GB1490955A (en) * 1974-07-19 1977-11-09 Battelle Memorial Institute Process for the preparation of liposomes
EP0153133A2 (en) * 1984-02-13 1985-08-28 Marquette University Assembling multilayers of polymerizable surfactant on a surface of a solid material
EP0154620A2 (en) * 1984-03-09 1985-09-11 Uwe B. Dipl.-Ing. Dr. Sleytr Structure with membranes having pores extending throughout, process for producing this structure and its uses
WO1986003685A1 (en) * 1984-12-21 1986-07-03 Sleytr Uwe B Process for changing the effective pore size of a structure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000060A1 (en) * 1983-06-15 1985-01-03 Neal Keith Jones Thin plastic corrector lenses for optical systems

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3736204A (en) * 1969-08-08 1973-05-29 American Cyanamid Co Reverse osmotic water purification
US3892665A (en) * 1973-10-15 1975-07-01 Standard Oil Co Membrane method and product
GB1490955A (en) * 1974-07-19 1977-11-09 Battelle Memorial Institute Process for the preparation of liposomes
EP0153133A2 (en) * 1984-02-13 1985-08-28 Marquette University Assembling multilayers of polymerizable surfactant on a surface of a solid material
EP0154620A2 (en) * 1984-03-09 1985-09-11 Uwe B. Dipl.-Ing. Dr. Sleytr Structure with membranes having pores extending throughout, process for producing this structure and its uses
WO1986003685A1 (en) * 1984-12-21 1986-07-03 Sleytr Uwe B Process for changing the effective pore size of a structure

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Abstract 144531q, Biochim Biophys Acta 1973, 298(3), 750-4 *
Angew Chem Vol 83 published 1971 p 677-90 see p 676-8 (KUHN H, MOBIUS D) "Systeme aus Monomolekularen Schichten-Zusammenbau und Physikalisch-Chemisches Verhalten" *
Angew Chemie Vol 93, p 311-29 published 1981 (GROS L et al) "Polymere Antitumor Mittel auf Molekularer und Zellularer Basis" see p 322-23 *
Chem & Eng News Vol 62, No 1, p 25-38 published January 2, 1984. (FENDLER J H) "Membrane Mimetic Chemistry" *
CHEMICAL ABSTRACTS Vol 78 (1973) Abstracts 144529n, J Membrane Biol 1973, 11(3), 237-54 and *
Upsala J Med Sci Vol 81 published 1976, p 193-200 (CERVEN E) "The Fluid Double Polar-Nonpolar-Polar Leaflet Model for Biological Membranes" *
Upsala J Med Sci Vol 89 published 1977, p 167-181 (CERVEN E) "The Plasma Membrane Consists of Two Polar-Nonpolar-Polar Leaflets" *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992016209A1 (en) * 1991-03-14 1992-10-01 Reanal Finomvegyszergyár Granules and veterinary compositions comprising a water-soluble complex of flumequine

Also Published As

Publication number Publication date
NZ214495A (en) 1988-02-12
AU6738787A (en) 1987-06-30
US5080936A (en) 1992-01-14
EP0248877A1 (en) 1987-12-16

Similar Documents

Publication Publication Date Title
Dimova et al. The giant vesicle book
Sessa et al. Interaction of a lytic polypeptide, melittin, with lipid membrane systems
Terwilliger et al. The structure of melittin in the form I crystals and its implication for melittin's lytic and surface activities
Popot et al. Membrane protein folding and oligomerization: the two-stage model
Kidwai et al. Studies on smooth muscle plasma membrane: I. Isolation and characterization of plasma membrane from rat myometrium
Tamm Incorporation of a synthetic mitochondrial signal peptide into charged and uncharged phospholipid monolayers
Frey et al. Membrane insertion and lateral diffusion of fluorescence-labelled cytochrome c oxidase subunit IV signal peptide in charged and uncharged phospholipid bilayers
EP0441120A2 (en) Biosensors
EP0374181A1 (en) Method of manufacturing unilamellar lipid vesicles
US5080936A (en) Method for the assembly of polar-nonpolar-polar proteolipid membranes
US20080160313A1 (en) Lipid bilayers on nanotextured solid surfaces
Chanturiya et al. Short-chain alcohols promote an early stage of membrane hemifusion
Van der Steen et al. Glycophorin incorporation increases the bilayer permeability of large unilamellar vesicles in a lipid-dependent manner
Anner Interaction of (Na++ K+)-ATPase with artificial membranes. I. Formation and structure of (Na++ K+)-ATPase-liposomes
Avdeef High‐throughput Measurement of Permeability Profiles
Wang et al. Local anesthetic-membrane interaction: a multiequilibrium model.
US20120214708A1 (en) Device and Process for Measuring Cell Properties
McFarlane The ultracentrifugal analysis of normal and pathological serum fractions
Akimov et al. Ganglioside GM1 increases line tension at raft boundary in model membranes
Papahadjopoulos Phospholipid membranes as experimental models for biological membranes
Alfsen Membrane dynamics and molecular traffic and sorting in mammalian cells
US20220266205A1 (en) Active phospholipid membrane and related production process
AU617123B2 (en) Method of manufacturing unilamellar lipid vesicles
US20230258665A1 (en) Membrane protein analysis substrate, method of producing membrane protein analysis substrate, method of analyzing membrane protein and membrane protein analysis grid
Harris The proteins released from intact erythrocyte ghosts' at low ionic strength.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR CH DE DK FI GB HU JP KP KR LK LU MC MG MW NL NO RO SD SE SU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG

WWW Wipo information: withdrawn in national office

Ref document number: 1987900317

Country of ref document: EP

WR Later publication of a revised version of an international search report
WWP Wipo information: published in national office

Ref document number: 1987900317

Country of ref document: EP

CFP Corrected version of a pamphlet front page

Free format text: THE IPC SYMBOL SHOULD READ "B01D 13/04" INSTEAD OF "B01J 13/04"

WWE Wipo information: entry into national phase

Ref document number: 1987900317

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642